NewsBenzingaUBS mantiene il rating Buy su Celestica, alza il target price a 453 dollari UBS mantiene il rating Buy su Celestica, alza il target price a 453 dollari Benzinga 2026.10.28 21:21 (GMT+0) Open on Benzinga Other news Lake Street Maintains Buy on OrthoPediatrics, Raises Price Target to $38 If You Invested $1000 In Applied Materials Stock 15 Years Ago, You Would Have This Much Today Lake Street Initiates Coverage On C4 Therapeutics with Buy Rating, Announces Price Target of $11 Dear AMD Stock Fans, Mark Your Calendar for November 3 Freedom Broker Upgrades Dorman Products to Buy, Lowers Price Target to $152 AstraZeneca PLC (AZN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress - Slideshow (NYSE:AZN) 2026-10-28
AstraZeneca PLC (AZN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress - Slideshow (NYSE:AZN) 2026-10-28
